What's next for CRISPR? Cas9, Cas3 and beyond

International researchers have developed a new CRISPR tool, Cas3, likened to a "DNA shredder with a motor"

Add bookmark

International researchers have collaborated on a new CRISPR-based tool, CRISPR-Cas3 which has been likened to a “DNA shredder with a motor”. This is distinct from CRISPR-Cas9 which has been described as single-sequence targeting ‘scissors’[1].

Read our complete guide to CRISPR Cas9

CRISPR-Cas3 has the ability to erase long stretches of DNA from a targeted site within the genome.  Using this tool, researchers can scan the genome and detect non-coding genetic elements. These elements then act as regulators, controlling the expression of proteins in coding genes, a significant aspect of cell differentiation and sex determination.

CRISPR Cas3 has been likened to a "DNA shredder with a motor"

As Yan Zhang, study leader at the University of Michigan, put it “Cas9 is a molecular scissor that goes where you want it and snips once. Cas3 goes where you want it, travels along the chromosome, and makes a spectrum of deletions tens of kilobases long”[2].  The scale of this tool could give it powerful screening abilities particularly for determining which large areas of DNA are relevant for certain diseases.

Cas3 may also be a significant development for the treatment of viruses, with suggestions that it could find and erase ectopic viruses, such as herpes simplex and hepatitis B. Ailong Ke, professor of molecular biology and genetics said that this tool “can be made to target these viruses very specifically and then erase them very efficiently. In theory it could provide a cure for these viral diseases” [3].

In the latest tests, researchers used Cas3 in HAP1 cells and human embryonic cells, deleting DNA sequences up to 100,000 base pairs.

Read more: How CRISPR immunity and mathematical cryptanalaysis may change the future of personalized medicine

In a recent podcast on humanOS[4] Paul Garofolo, CEO of Locus Biosciences, compared the Cas3 tool to PAC-MAN. As he put it, Cas3 can be used to “to go in [to the cell] and…identify a base pair location. Instead of making a double strand cut [similar to Cas9], it recruits what behaves like a PAC-MAN. It makes a small nick on one strand of the DNA, recruits that PAC-MAN, and it unzips, unwinds and permanently destroys one strand of DNA around the entire genome of a bacteria cell”[5].

"[Cas3] unzips, unwinds and permanently destroys one strand of DNA around the entire genome of a bacteria cell"

Ailong Ke did note that this ability to attack a large section can also be a risk. He pointed out that the team “can’t quite define the deletion boundaries precisely and that is a shortcoming when it comes to therapeutics”[6].  The team have made strides though to understand what the Cas3 has shredded, developing custom informatics pipelines to analyse deep sequencing results and building sensitive, dual-reporter cell lines[7]. Although the researchers do believe there is insight to be gained from “shredding” sections of DNA and analysing what changes occur as a result[8].

Thus far, CRISPR-Cas9 has been the standard CRISPR tool, but researchers have experimented with other forms. Cas12a and Cas12b have been said to be more precise variations which are easier to use. While CasX is a smaller variant which enables easier access routes to cells. The newest development of CRISPR-Cas3 is perhaps only signalling that there is far more that can and will be achieved with these tools.

 

[1] https://www.cell.com/molecular-cell/fulltext/S1097-2765(19)30217-5

[2] https://www.biotechniques.com/crispr/crispr-upgraded-from-scissors-to-shredder/

[3] https://news.cornell.edu/stories/2019/04/crispr-cas3-innovation-holds-promise-disease-cures-advancing-science

[4] https://blog.humanos.me/antibiotics-are-losing-efficacy-crispr-cas-3-pac-man-may-save-us-guest-paul-garofolo-ceo-locus-bio/

[5] https://blog.humanos.me/antibiotics-are-losing-efficacy-crispr-cas-3-pac-man-may-save-us-guest-paul-garofolo-ceo-locus-bio/

[6] https://news.cornell.edu/stories/2019/04/crispr-cas3-innovation-holds-promise-disease-cures-advancing-science

[7] https://www.uofmhealth.org/news/archive/201904/new-dna-%E2%80%9Cshredder%E2%80%9D-technique-goes-beyond-crispr%E2%80%99s-scissors

[8] https://newatlas.com/crispr-cas3-dna-shredder/59214/


Upcoming Events

Cosmetic Compliance New York 2016

October 17 - 19, 2016

MANHATTAN NYC – An Affinia Hotel Collection, New York, NY

Cosmetic Compliance New York 2016

Pharma Traceability November - 2016

November 30 - December 2, 2016

Sheraton Philadelphia University City Hotel, Philadelphia, PA

Pharma Traceability November - 2016

UDIs and Traceability for Medical Devices

15 - 18 May, 2018

Pullman Brussels Centre Midi Hotel, Brussels, Belgium

UDIs and Traceability for Medical Devices

CRISPR: A New Era in Gene Editing

December 5 - 7, 2016

Embassy Suites by Hilton Boston at Logan Airport, Boston, MA

CRISPR: A New Era in Gene Editing

10. Jahreskonferenz Pharma Packaging 2016

29 February - 2 March, 2016

Golden Tulip Berlin - Hotel Hamburg, Berlin, Germany

10. Jahreskonferenz Pharma Packaging 2016

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended